UK Version HeadaTerm 2.0 Anti-migraine Device

UK Version HeadaTerm 2.0 Anti-migraine Device

HeadaTerm is a healthcare solutiontrading and manufacturer focusing on waerable andtreatable electronic wrist device for anti-migraine and extending to medical consumables.We consist of leaders in the field of medical research and product development who are devoted to provide effective and convenient therapy options to users around the world now. We have over10 years experience in medical business, approved withFDA, UKCA and ISO etc.HeadaTerm 2.0 Anti-migraine Device - UK Version exported to over 20 authorized distributors worldwide, covering markets in more than 30 countries or regions including the United States, Canada, the United Kingdom, Australia, and Japan. We are looking for more  business partner and cooperation around the world .

HeadaTerm 2.0 Anti-migraine Device - UK Version introduction

HeadaTerm 2.0 Anti-migraine Device - UK Version is a clinically proven, safe, and effective medical device worn on users’ foreheads that uses none-invasive neuronal electrical stimulation technology to prevent and treat primary headache, including migraine, tension headache, and cluster headache. Primary headaches are debilitating conditions that are extremely common among people. Drug treatments are the popular solutions for many patients, but just like with anti-nausea drugs, there are side effects that often turn people away.HeadaTerm 2.0 Anti-migraine Device - UK Version offers a drug-free treatment without any side effects. We provide anone year warranty for all produces.  Our product is easy to install and charging. We have helped a lot people suffering from motion sickness. They felt absolutely no nausea and enjoy life now.

 Anti-migraine device

- The device is the world’s first disposable wearable device for migraine, insomnia,

and depression. Worn like a band-aid over the forehead, it is unencumbered by

pharmaceutical side effects.

- The device uses targeted neuromodulation. By using specifically modulated

electrical stimulation to target the dorsolateral prefrontal cortex, it is able to

stimulate endorphin release, increasing threshold for pain sensation as well as

promoting pleasure.

- The device has received clearance from the U.S. (FDA), European Union (CE),

Canada (HC), Australia (TGA), and China (CFDA). The device can be sold in

pharmacies and over-the-counter.

- Clinical studies shown effectiveness as high as 91%, reducing pharmaceutical

intake by up to 75%.

Adjustable Stimulation Intensity

The intensity of the treatment will increase to the strongest level within five minutes. During this period, users can choose the appropriate intensity according to their own experience to achieve the best effect.

Compact And Easy To Carry

HeadaTerm is very small and light, making it convenient not only to use at home or at the office, but also on trips and outdoor travelling.

Principle

Primary headaches, such as migraine, are transmitted by the supraorbital nerve and the supratrochlear nerve. HeadaTerm introduces precise electric impulses from the user’s forehead to act on these nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users. Every device contains 21 rounds of standard therapies, each therapy lasts 20 minutes.